Department of Cardiology, Peking University First Hospital, Beijing 100034, China.
J Zhejiang Univ Sci B. 2011 Aug;12(8):629-32. doi: 10.1631/jzus.B1101010.
Reperfusion is the key strategy in acute ST-segment elevation myocardial infarction (STEMI) care, and it is time-dependent. Shortening the time from symptom to reperfusion and choosing the optimal reperfusion strategy for STEMI patients are great challenges in practice. We need to improve upon the problems of low reperfusion rate, non-standardized treatment, and economic burden in STEMI care. This article briefly reviews the current status of reperfusion strategy in STEMI care, and also introduces what we will do to bridge the gap between the guidelines and implementation in the clinical setting through the upcoming China STEMI early reperfusion program.
再灌注是急性 ST 段抬高型心肌梗死（STEMI）治疗的关键策略，且具有时间依赖性。缩短 STEMI 患者从症状发作到再灌注的时间，并为其选择最佳的再灌注策略，是目前临床实践中的重大挑战。我们需要解决 STEMI 治疗中再灌注率低、治疗不规范和经济负担重等问题。本文简要综述了 STEMI 治疗中再灌注策略的现状，并介绍了即将开展的中国 STEMI 早期再灌注项目，我们将通过该项目来弥合指南与临床实践之间的差距。
